Publications

September 2020 (Revised January 2021)
Case

Catalys Pacific

By: Joshua Lev Krieger

In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After... View Details

Keywords: Pharmaceutical Companies; Biotech; Health Care; Entrepreneur; Innovation; International Business; Entrepreneurial Finance; Entrepreneurship; Finance; Innovation Strategy; Venture Capital; Strategy; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; Biotechnology Industry; Tokyo

1991
Other Unpublished Work

Japanese Corporate Finance and Governance: Implications for the Privatization of Eastern European Economies

By: David S. Scharfstein

Keywords: Privatization; Corporate Governance; Developing Countries and Economies; Corporate Finance; Japan; Europe

22 Mar 2018
Blog Post

“Mission + Profit: What’s the Balance?” asks SECON 2018

from as far as Japan and New Zealand. It was a great honor and experience to meet students, professionals and practitioners hailing from many parts of the world. SECON kicked off to a great start as Matt Forti, Managing Director of One... View Details

Keywords: Manufacturing; Nonprofit / Government; Technology; Entrepreneurship; Health Care

Profile

Casey Gerald

book of second-year EC colleagues. When he wanted to know more about consumer goods in Asia, he found an expert on retailing in Japan through the Retail & Luxury Goods Club. “Second,” says Casey, “HBS is uniquely suited to prepare me... View Details

18 Oct 2017
Blog Post

4 Advantages of the MS/MBA: Engineering Sciences Program

AI. I get the exciting challenge of building our business in Japan while honing my technical skills! My MBA is already paying dividends in my new job, but I’m also having to re-learn some of my previous technical skills. The unique... View Details

January 2021
Supplement

Takeda Pharmaceutical Company Limited (B)

By: David J. Collis, Nobuo Sato and Akiko Kanno

This case is a follow up to HBS Case No. 721-373, Takeda Pharmaceutical Company Limited (A). Following the events of the previous case, Takeda reached an agreement to acquire Ireland-based Shire Plc. The case follows some of the achievements and challenges Takeda and... View Details

Keywords: Pharmaceutical Companies; Pharmaceuticals; M＆A; Mergers ＆ Acquisitions; Biotech; Biotechnology; R＆D; Talent Management; Mergers and Acquisitions; Globalization; Global Strategy; Talent and Talent Management; Strategy; Biotechnology Industry; Pharmaceutical Industry; Japan; Asia

December 2018 (Revised October 2020)
Case

Shiseido: Reinvesting in Brand

By: Jill Avery and Nobuo Sato

Shiseido was in the midst of a six year corporate turnaround, trying to reverse the effects of decades of under-investment in R&D and marketing which had led to a cycle of declining customer support and brand value. Would the CEO’s VISION 2020 plan, centered on four... View Details

March 2007 (Revised March 2008)
Case

The Nikkei 225 Reconstitution

By: Robin Greenwood

Taka Haneda, a proprietary trader at the Tokyo office of Goldman Sachs, has just learned that the Nikkei 225 will undergo a significant redefinition over the coming week. He faces several billion dollars of customer orders, as well as the opportunity to commit the... View Details

Keywords: Financial Liquidity; Stocks; Investment Return; Price; Market Transactions; Financial Services Industry; Tokyo

October 2006 (Revised March 2007)
Case

Production I.G: Challenging the Status Quo

By: Andrei Hagiu, Tarun Khanna, Felix Oberholzer-Gee, Masako Egawa and Chisato Toyama

In July 2006, Mitsuhisa Ishikawa wondered how he could further enhance the success and visibility of his animation production company headquartered in Tokyo, Production I.G. For the year ended May 2006, Production I.G. had sales of 5,439 million yen ($47.3 million),... View Details

Keywords: Business Growth and Maturation; Competitive Advantage; Markets; Animation Entertainment; Going Public; Growth and Development Strategy; Motion Pictures and Video Industry; Tokyo